1205 East Washington Street | Suite 111 | Louisville, KY | 40206

Woman Says Onglyza Led to Her Mother’s Heart Failure

Woman Says Onglyza Led to Her Mother’s Heart Failure

Onglyza is a Type 2 diabetes drug, classified as a DPP-4 inhibitor. It works by making the pancreas create insulin and preventing the liver from producing extra sugar. Recently, however, the drug has been under scrutiny due to an emerging link between Onglyza and heart failure. This risk of heart failure, along with the potential risks of pancreatitis, pancreatic cancer, and thyroid cancer, had lead to patients filing Onglyza lawsuits against the drug’s manufacturer.

Onglyza’s Link to Heart Conditions

In 2008, the U.S. Food and Drug Administration (FDA) told AstraZeneca, the manufacturers of Onglyza, that they needed to prove that their drug did not increase the risk of cardiovascular problems. However, no conclusive studies were performed until early 2014.

In February of 2014, the FDA requested that a clinical trial be performed to investigate the link between Onglyza and heart failure. During this study, 16,000 patients were tested. The results were shocking: 27% more of the Onglyza patients were hospitalized for heart failure compared to the control group.

After this study, in April 2015, the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 14-1 to place stronger warnings about Onglyza’s heart risks on the drug’s label. One committee member voted to recall the drug altogether.

Lawsuit Against the Makers of Onglyza

On October 29, 2015, a Chicago woman named Rochelle Gibson filed an Onglyza lawsuit on behalf of her deceased mother, Lillie Ree Gibson. The daughter claims that Onglyza contributed to her mother’s heart failure, and ultimately, her death.

Lillie began taking the Type 2 diabetes drug Onglyza in 2010 after it was prescribed by her doctor. A year later, in 2011, Lillie suffered heart failure and was hospitalized for her heart problems twice in 2013. She died later that year in October 2013.

Rochelle is filing a lawsuit against the drug’s maker, AstraZeneca, and had requested a trial by jury. She is seeking over $50,000 in damages, in addition to legal fees and punitive damages.

Contact an Onglyza Attorney

At Jones Ward, PLC we know just how difficult a drug-related illness or injury can be for you and your family. That’s why we are determined to hold manufacturers responsible for their dangerous drugs, make sure you get the compensation you deserve, and lift some of the stress off your shoulders. If you’ve experienced the negative effects of Onglyza, you should contact an attorney as soon as possible. To find out how to get started, fill out our free case evaluation or call us at 888-595-2922.